Morey, R., Logue, M., Maihofer, A. X., Nievergelt, C., Ashley-Koch, A., Garrett, M., … Thompson, P. (2023). PROGRESS AND PROMISE OF NEUROGENETICS METHODS TO STUDY PTSD. In European Neuropsychopharmacology (Vol. 75, pp. S40–S40). Elsevier BV. https://doi.org/10.1016/j.euroneuro.2023.08.082

Morey, Rajendra, Mark Logue, Adam X. Maihofer, Caroline Nievergelt, Allison Ashley-Koch, Melanie Garrett, Courtney Haswell, et al. “PROGRESS AND PROMISE OF NEUROGENETICS METHODS TO STUDY PTSD.” In European Neuropsychopharmacology, 75:S40–S40. Elsevier BV, 2023. https://doi.org/10.1016/j.euroneuro.2023.08.082.

Morey R, Logue M, Maihofer AX, Nievergelt C, Ashley-Koch A, Garrett M, et al. PROGRESS AND PROMISE OF NEUROGENETICS METHODS TO STUDY PTSD. In: European Neuropsychopharmacology. Elsevier BV; 2023. p. S40–S40.

Morey, Rajendra, et al. “PROGRESS AND PROMISE OF NEUROGENETICS METHODS TO STUDY PTSD.” European Neuropsychopharmacology, vol. 75, Elsevier BV, 2023, pp. S40–S40. Crossref, doi:10.1016/j.euroneuro.2023.08.082.

Morey R, Logue M, Maihofer AX, Nievergelt C, Ashley-Koch A, Garrett M, Haswell C, Mufford M, Dalvie S, Katrinli S, Medland SE, Thompson P. PROGRESS AND PROMISE OF NEUROGENETICS METHODS TO STUDY PTSD. European Neuropsychopharmacology. Elsevier BV; 2023. p. S40–S40.